Investigate the digestive microbiota and bacterial translocation during IBD and PD |
– |
Not applicable |
Recruiting |
NCT04159727 |
Treatment is able to restore the gut microbiota |
Rifaximin |
Phase 2 |
Recruiting |
NCT03958708 |
Resistant maltodextrin for gut microbiome in Parkinson’s disease |
Maltodextrin |
Phase 2 |
Recruiting |
NCT03667404 |
Brain–gut–microbiota axis and initiation of α-syn misfolding |
– |
Not applicable |
Not yet recruiting |
NCT03710668 |
Gut-derived neuropeptides in cerebrospinal fluid of patients with Parkinson’s disease and healthy controls |
Certain gut-derived peptides (ghrelin, GLP-1) |
– |
Completed |
NCT01792193 |
Effects of resistant starch on bowel habits, fecal short chain fatty acids and gut microbiota in Parkinson disease (RESISTA-PD) |
Resistant starch |
– |
Completed |
NCT02784145 |
Study of the genome, gut metagenome and diet of patients with incident Parkinson’s disease (16S rRNA gene sequencing) |
– |
|
Recruiting |
NCT04119596 |
Increased gut permeability to lipopolysaccharides (LPS) in Parkinson’s disease |
– |
– |
Completed |
NCT01155492 |
Possible role of bacteria of the nose and gut in the pathogenesis of PD |
– |
– |
Completed |
NCT01536769 |
Role of gut flora in Parkinson’s disease |
– |
– |
Recruiting |
NCT04148326 |
Gut microbiota across early stages of synucleinopathy |
– |
– |
Recruiting |
NCT03645226 |
Parkinson’s disease and digestive health (neuroenteric dysfunction) |
– |
|
Recruiting |
NCT04032262 |
Probiotics-prebiotic fiber therapy in Parkinson’s disease patients with constipation |
Probiotics with prebiotic |
Phase 3 |
Completed |
NCT04451096 |
Study of the fecal microbiome in patients with Parkinson’s disease |
PRIM-DJ2727 |
Phase 1 |
Recruiting |
NCT03671785 |
Dietary intervention and gastrointestinal function in patients with Parkinson’s disease (MED) |
Mediterranean diet |
Not applicable |
Active, not recruiting |
NCT03851861 |
Fecal microbiota transplantation for Parkinson’s disease |
– |
– |
Recruiting |
NCT03808389 |
Study of the enteric nervous system using colonic biopsies in Parkinson patients with LRRK2 mutation (EnteroLarc) |
– |
– |
Terminated (lack of patients) |
NCT01618383 |